ReviewFrontiers in medicine2020

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents.

Leanna M Wise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.